About half of people with gout don't have treatments that work. Meet the new gout drugs racing through trials to reach them.

Opioid use and abuse is a significant social, health and economic issue in Canada. Researchers at the University of Calgary's Faculty of Veterinary Medicine (UCVM) and Hotchkiss Brain Institute (HBI) ...

As a child, James Mackay watched his father struggle just to stand up. “You shouldn’t have eaten this or that,” his mother ...

Gout patients with kidney problems got better uric acid control from an extended-release version of febuxostat than from the ...

GLASGOW, Scotland — Whether anti-inflammatory drugs should always be used to prevent flares when initiating urate-lowering therapy (ULT) for gout remains an open question as experts discussed its ...

Atom’s focus on chronic and acute gout aims to combat a growing worldwide gout threat with few safe and effective existing treatments for patients. Lingdolinurad (ABP-671), a new URAT1 inhibitor, has ...

Gout, a type of inflammatory arthritis caused by a buildup of uric acid (urate) in the body, affects 5.1% of U.S. adults (over 12 million), including 10% of those aged 65 or older. Urate is produced ...

A major new study reveals that treating gout may do far more than ease painful joint flare-ups—it could also protect the heart. Researchers found that patients who took common gout medications like ...

A higher rate of weight loss within 1 year of initiating orlistat is associated with lower risks for incident gout and recurrent gout flares in individuals with body mass index (BMI) > 25, ...